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A B S T R A C T
Preformed spacers have proved to be effective in the two-stage revision of infected total hip
replacements. In the treatment of septic arthritis of the hip, the use of a temporary device has
occasionally been described, but the implantation of a preformed antibiotic-loaded spacer has not yet
been reported. A 71-year-oldmanwith a destructive Staphylococcus aureus septic arthritis of the hip joint
was admitted to hospital. Given the persistence of local infection regardless of all antibiotics and the
worsening of joint damage, an aggressive surgical treatment including early placement of a preformed
temporary spacer loaded with antibiotics was performed. Two months later an uncemented total hip
replacement was successfully implanted. Two years after surgery the patient had a complete functional
recovery with no signs of recurrence. The advantages of a preformed device include an effective and
predictable local release of antibiotics and a mechanically tested resistance that allows early partial
weight bearing and immediate joint mobilization.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Primary septic arthritis in an adult is a rare, but potentially
devastating disease, the knee being the most commonly affected
joint. Several risk factors, including diabetes, rheumatoid arthritis,
steroid therapy, alcoholism, chronic liver or kidney disease, cancer,
malnutrition, and immune deﬁciencies, are associated with septic
arthritis of the hip joint.1
Two-stage revision with the use of an antibiotic-loaded acrylic
cement spacer is a well-established procedure in the management
of chronically infected total hip replacement (THR).2–5 The
effectiveness of a temporary spacer in the treatment of hip and
knee septic arthritis has occasionally been reported.1,6–8
We describe the ﬁrst case of destructive septic arthritis of the
hip joint that was managed successfully by means of a two-stage
THR using a preformed cement spacer.
2. Case report
A 71-year-old male was admitted to the rheumatology
department of our local hospital because of the onset of increasing
pain in his right hip. Symptoms had started onemonth earlier with
a diffuse arthritis after a febrile episode. Laboratory tests revealed a* Corresponding author. Tel.: +39 45 8124471; fax: +39 45 8027470.
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rate of 101 mm/h, and a serum white blood cell count of
14.9  109/l. An acute arthritis caused by parvovirus B19 was
diagnosed (serological studies detected IgM antiparvovirus) and
successfully treated with intravenous administration of immu-
noglobulins. At this time, no additional assessment was carried out
in order to rule out possible septic arthritis.
In the following weeks the patient complained of a worsening
right hip pain, and pelvis radiographs showed early degenerative
changes. An ultrasound exam demonstrated an articular ﬂuid, and
aspiration yielded a methicillin-sensitive Staphylococcus aureus
(MSSA). Physical examination showed an irritable hip joint and
inability to bear weight on the affected limb. Moreover, conven-
tional radiographs showed a rapidly progressive destruction of the
right hip (Figure 1). Unfortunately, an orthopedic evaluation was
not requested at this stage, and a conservative treatment was
undertaken by means of six-week administration of intravenous
antibiotics (ceftriaxone 2 g once daily for two weeks followed by a
four-week treatment with rifampin 600 mg daily).
Given the persistence of local infection regardless of all
antibiotics and the worsening of joint damage, an orthopedic
consultation was obtained and surgical treatment was planned.
The hipwas explored via an anterolateral approach. After resection
of the femoral head, meticulous debridement of all inﬂammatory
tissues was performed on the acetabular rim. An industrial
preformed temporary spacer (Spacer-G1, Tecres S.p.A., Somma-
campagna, Verona, Italy) was inserted in the femoral canalses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Anteroposterior radiograph taken four months after the onset of hip pain,
demonstrating a complete loss of the articular space and severe joint destruction.
Figure 3. X-ray taken two years following the uncemented total hip replacement.
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coated with bone cement supplemented with gentamicin sulfate
(1.9 g, 1.8% w/w) and vancomycin (2 g, 2.5% w/w). The persistence
of the MSSA infection was conﬁrmed through microbiological
cultures. The patient received organism-speciﬁc intravenousFigure 2. Postoperative X-ray assessment showing the antibiotic-loaded spacer
inserted in the femoral canal.antibiotics (teicoplanin 600 mg daily) for two weeks after surgery,
followed by oral administration of amoxicillin–clavulanate (1 g
three times daily) for a further four weeks.
The postoperative course was uncomplicated, and hip pain
decreased dramatically after the spacerwas implanted. The patient
was mobilized immediately and encouraged to undertake weight
bearing with crutches. Normalization of inﬂammatory markers
was detected three weeks after surgery and persisted over time,
supporting eradication of infection. An uncemented THR through
the same surgical approach was performed 63 days following
spacer implantation; at the time all serological parameters were
negative. Intraoperative specimens were collected for microbio-
logical examination and the cultures were all negative. A dosage of
1 g three times daily of amoxicillin–clavulanate was given
intravenously for two consecutive weeks after the second stage
surgery.
The patient then underwent quarterly controls including
clinical assessment, standard X-rays, and laboratory ﬁndings. At
the two-year follow-up no clinical or biohumoral evidence of
recurrence of infection was found, and functional outcome of the
THR was excellent (Figure 3).
3. Discussion
Several surgical options in association with systemic admin-
istration of antibiotics have been proposed to manage a septic
arthritis. The standard treatment of an acutely infected hip
involves joint decompression. Arthroscopic drainage of the hip
has been advocated, as this has the advantage of being a less
invasive procedure.9 Both open and arthroscopic techniques have
enhanced effectiveness in the early stages of infection when the
articular damage has not yet become established.
In the present case, the patient was ﬁrstly referred to our
orthopedic institution approximately four months after the onset
of pain. Radiological examination revealed a rapid narrowing of the
D. Regis et al. / International Journal of Infectious Diseases 14 (2010) e259–e261 e261joint space; in only a few months an extensive subchondral bone
loss developed in the acetabulum. Therefore, functional prognosis
of the hip joint was unfavorable and a poor clinical outcomewas to
be expected.
The persistence of an aggressive, antibiotic-resistant septic
arthritis suggested the immediate use of a temporary antibiotic-
loaded cement spacer in order to dominate the infection and
accelerate functional recovery following THR. Hip spacers have
proved to be an effective method in the treatment of infected joint
prostheses by means of the sustained antibiotic release.2–5
A two-stage THR without temporary devices for the treatment
of primary septic arthritis of the hip has been performed by Chen
et al.10 They reported a re-infection rate of 14% and a complication
rate of 36%. It is thought that the spacer could increase the infection
healing rate, reducing functional impairment during the ﬁrst stage
of treatment. More recently, a highly successful two-stage
approach to primary knee arthroplasty in infectious arthritis has
been presented.6,8
We found three reports mentioning the possibility of using a
temporary device in septic arthritis of the hip, but very little
information concerning this technical option was available.
Moreover, to our knowledge, this is the ﬁrst paper reporting the
implantation of a preformed spacer.
In 2003, Schoellner et al.11 reported a preliminary experience
with ﬁve individually manufactured bone cement spacers for
septic hip revision. The adaptability of this mechanically tested
system was emphasized and its indication in primary joint
infection was discussed with no additional details.
Morshed et al.7 described a case of septic arthritis of the hip
complicated with intrapelvic abscess following a single intra-
articular injection of hyaluronic acid. The implantation of an
antibiotic-impregnated cement block after unsuccessful surgical
debridement and partial resection of the femoral head eradicated
infection allowing the application of a hip prosthesis.
Recently, Barrett and Bal1 focused on local sepsis that occurred
spontaneously in a healthy adult, exhibiting a rapid radiographic
destruction of the hip joint. The patient ﬁnally underwent
placement of a temporary unspeciﬁed implant loaded with
antibiotics followed by uncomplicated THR.
Spacers provide a local delivery from acrylic bone cement of
highly concentrated antibiotics at the infected site. In the reported
case, early application of Spacer-G promoted healing of infection,
which was documented by the rapid and persistent normalization
of laboratory parameters. In vitro pharmacological tests have
already demonstrated the effective release of gentamicin and
vancomycin from the spacer we employed.12 Moreover, the
preformed device was experimentally investigated under cyclic
loading conditions, showing no risk ofmechanical failure following
assisted weight bearing.13 Consequently, a signiﬁcant improve-
ment of the patient’s quality of life was obtained during treatment
of infection, enabling his functional recovery.
In conclusion, a primary uncontrolled infected hip may beneﬁt
from a two-stage arthroplasty with preformed antibiotic-loaded
cement spacers. Spacer blocks provide an effective local antibioticrelease allowing early partial weight bearing and preservation of
the range of joint motion.
In the management of progressive and rapidly destructive,
antibiotic-resistant septic arthritis of the hip joint, the use of a
temporary antibiotic-impregnated cement spacer should be
considered in order to enable eradication of the infection and to
accelerate recovery of function following THR.
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